Articles by Jeffrey S. Buguliskis, PhD

  1. Cell & Gene Therapy Outsourcing's New Paradigm 10/7/2025

    The industry has flipped from scarcity to surplus, and sponsors now have leverage to set terms, not take numbers.

  2. Clear The Outsourcing Runway: The 8 Largest Deals In The Past Year 9/30/2025

    We ranked the past year’s eight biggest pharma–CDMO manufacturing deals and decoded what they signal for your next outsourcing project.

  3. Green Is The New KPI: Sustainability In Pharma Outsourcing 9/10/2025

    Sustainability is moving from marketing to metering, as sponsors look for facility-level metrics and contract incentives that drive measurable improvement.